checkAd
    Startseite > Aktien > Mind Medicine (MindMed) > Nachrichten
    Mind Medicine (MindMed) Aktie
    7,8250
     
    EUR
    -1,01 %
    -0,0800 EUR
    Letzter Kurs 08:08:16 Tradegate
    7,9150
     
    EUR
    380 STK
    Geldkurs 10:00:01
    8,0700
     
    EUR
    377 STK
    Briefkurs 10:00:01
    ISIN: CA60255C8850 · WKN: A3DR6E · SYM: MMQ · Kanada

    Neueste Nachrichten

    TOP-Performer!: 'Must have'! Psychedelika-Aktien gehören zu den Star-Performern in 2024! Jetzt zuschlagen!
    15.04.24 · Carsten Ringler · GF Global Cannabis Opportunity Fund EURAnzeige
    MindMed to Present at Upcoming April Medical Conferences
    02.04.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed Announces Voluntary Delisting from Cboe Canada
    01.04.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
    11.03.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
    07.03.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder
    07.03.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
    01.03.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed Reports 2023 Financial Results and Business Updates
    28.02.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results and Provide Business Update
    22.02.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed to Participate in the 34th Annual Oppenheimer Healthcare Life Sciences Conference
    07.02.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed Announces Business Update and Anticipated Milestones for 2024
    08.01.24 · Business Wire (engl.) · Mind Medicine (MindMed)
    MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder
    14.12.23 · Business Wire (engl.) · Mind Medicine (MindMed)